Location History:
- Schlieren, CH (2016)
- Zurich, CH (2019)
Company Filing History:
Years Active: 2016-2019
Title: The Innovative Contributions of Wenjuan Zha
Introduction
Wenjuan Zha is a prominent inventor based in Zurich, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic polypeptides. With a total of 2 patents, her work focuses on innovative solutions for medical applications.
Latest Patents
Wenjuan Zha's latest patents include groundbreaking inventions such as "Antibody-fynomer conjugates" and "IL-17A binding molecules and medical uses thereof." The first patent describes a bi-specific fusion polypeptide that comprises a fynomer sequence binding to interleukin-17a (IL-17a) and is conjugated to an antibody that binds to interleukin-6 receptor (IL-6R). This innovative fusion polypeptide can effectively suppress the activities of both IL-17a and IL-6R. The second patent relates to a polypeptide that inhibits the activity of glycosylated IL-17A, featuring specific amino acid sequences that are crucial for its function. This invention also encompasses fusion constructs, compositions, and various medical uses.
Career Highlights
Throughout her career, Wenjuan Zha has worked with notable companies such as Mitsubishi Tanabe Pharma Corporation and Covagen AG. Her experience in these organizations has allowed her to refine her expertise in biopharmaceutical development and innovation.
Collaborations
Wenjuan has collaborated with esteemed colleagues, including Dragan Grabulovski and Richard Woods. These partnerships have contributed to her success in advancing her research and patent applications.
Conclusion
Wenjuan Zha's innovative work in biotechnology and her impressive patent portfolio highlight her significant contributions to medical science. Her dedication to developing effective therapeutic solutions continues to impact the field positively.